TVARDI THERAPEUTICS, INC. Contract Liability (Deferred Revenue)
TVARDI THERAPEUTICS, INC. (TVRD) had Contract Liability (Deferred Revenue) of $511.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Balance Sheet › Liabilities › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2021-02-25
- 2020-09-30: Contract with Customer, Liability, Current $511.00K.
- 2020-06-30: Contract with Customer, Liability, Current $9.77M.
- 2020-03-31: Contract with Customer, Liability, Current $14.24M.
- 2019-12-31: Contract with Customer, Liability, Current $22.26M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2020-09-30 | $511.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $9.77M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $14.24M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $22.26M 10-K · filed 2021-02-25 |
| 2019-09-30 | $26.77M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $26.47M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $28.19M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $26.82M 10-K · filed 2020-02-27 |
| 2018-09-30 | $29.24M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $22.27M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |